...
首页> 外文期刊>The lancet oncology >Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy
【24h】

Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy

机译:利妥昔单抗联合CHOP治疗孕中期弥漫性大B细胞淋巴瘤

获取原文
获取原文并翻译 | 示例
           

摘要

A 31 year old woman presented with an enlarged left supradavicular lymph node and without constitutional symptoms at 15 weeks' gestation during her first pregnancy. A Tru-cut biopsy showed a diffuse, large, B-cell non-Hodgkin lymphoma. MRI of neck, chest, abdomen, and pelvis showed enlarged lymph nodes in both the mediastinum and the left supradavicular area and in the fetus (figure 1). Biopsy samples and aspirate of bone marrow did not show infiltration by tumour cells. Haemoglobin was 11-4- g/L, whereas results of all other laboratory tests, induding lactate-dehydrogenase concentrations, were within normal ranges. The patient was therefore diagnosed with stage IIA diffuse large B-cell non-Hodgkm's lymphoma (low risk on the international prognostic index).
机译:一名31岁的妇女在第一次怀孕期间妊娠15周时,左上眼上淋巴结肿大,没有体质症状。 Tru-cut活检显示为弥漫性,大的B细胞非霍奇金淋巴瘤。颈部,胸部,腹部和骨盆的MRI检查显示,纵隔和左上眼球区域以及胎儿的淋巴结均增大(图1)。活检样本和骨髓穿刺活检未显示肿瘤细胞浸润。血红蛋白为11-4- g / L,而所有其他实验室测试的结果,包括乳酸脱氢酶浓度,均在正常范围内。因此,该患者被诊断为IIA期弥漫性大B细胞非霍奇克淋巴瘤(国际预后指标风险较低)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号